Using this model we have demonstrated that the reduced expression of GFI1 or presence of GFI1-36N accelerated progression to AML in the NUP98-HOXD13 murine model with MDS [6,26]. This evidence concerns the gene HOXD13 and myelodysplastic syndrome.